pentobarbital decreases amounts of vandetanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration with powerful CYP3A4 inducers; these prescription drugs reduce publicity to vandetanib by approximately 40%.The excretion of unmetabolized barbiturate is one aspect that distinguishes the long-per